Loading
Life sciences · Journal article
Frontiers in Cardiovascular Medicine · November 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Obstructive sleep apnea (OSA) is closely associated with and represents a potential biological contributor to the onset and progression of heart failure with preserved ejection fraction (HFpEF). Although abundant studies have clarified the associations of OSA with cardiovascular diseases including hypertension, coronary artery disease, arrhythmia and heart failure with reduced ejection fraction (HFrEF), the exact pathophysiological mechanisms underlying OSA-related HFpEF remain poorly elucidated, and relevant systematic reviews are still scarce. This review summarizes the pathophysiological links and clinical correlations between OSA and HFpEF. Beyond classical mechanisms such as intrathoracic pressure swings and sympathetic overactivation, we highlight the pivotal roles of systemic inflammation, obesity, vascular injury and metabolic dysfunction in disease progression. We further elaborate how these interactive pathological pathways shape a clinically identifiable OSA–HFpEF phenotype, and summarize phenotype-based diagnostic strategies. Moreover, we discuss therapeutic implications for targeted management for patients with isolated OSA and comorbid OSA-HFpEF. Finally, we outline existing limitations and future research perspectives in the mechanistic exploration, diagnosis and management of OSA-HFpEF comorbidity.